Further investigation of functional effects of COX-2 blockade on interaction of tumor cells and stroma may assist in better understanding of these alterations, and in optimizing the use of anti-VEGF treatments in cancer patients at risk for metastatic progression. The gene discussed is PTGS2; the disease is cancer.